Your Twin learns with you

30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Mário Gomes-Pereira

Has grant

Senior Research Scientist (Directeur de Recherche)

INSERM
Country flagFrance

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Sleep alterations in mouse models of DM1

Open Date: 2026-01-01

Close Date: 2027-12-01

Grant: Open

Gene therapy for CNS dysfunction in DM1: from cell-specific mechanisms to reversible symptoms and pre-clinical assessment of therapeutic strategies

Open Date: 2026-01-01

Close Date: 2033-01-01

Grant: Open

Interdisciplinary doctoral training on oligonucleotide-based therapies for myotonic dystrophy

Open Date: 2025-03-01

Close Date: 2029-02-01

Grant: Open

RNA biology and neuroglial function: resolving the cellular and subcellular transcriptome in myotonic dystrophy brains, towards new brain gene therapy

Open Date: 2025-03-01

Close Date: 2027-02-01

Grant: Open

Brain-specific magnetic resonance biomarkers of myotonic dystrophy type 1

Open Date: 2025-01-01

Close Date: 2028-12-01

Articles (3)

Year:

2025

Year:

2025

Aims Myotonic dystrophy type I (DM1) is one of the most frequent muscular dystrophies in adults. Although DM1 has long been considered mainly a muscle disorder, growing evidence suggests the involvement of peripheral nerves in the pathogenicity of DM1 raising the question of whether motoneurons (MNs) actively contribute to neuromuscular defects in DM1. Methods By using micropatterned 96‐well plates as a coculture platform, we generated a functional neuromuscular model combining DM1 and muscleblind protein ( MBNL ) knock‐out human‐induced pluripotent stem cells‐derived MNs and human healthy skeletal muscle cells. Results This approach led to the identification of presynaptic defects which affect the formation or stability of the neuromuscular junction at an early developmental stage. These neuropathological defects could be reproduced by the loss of RNA‐binding MBNL proteins, whose loss of function in vivo is associated with muscular defects associated with DM1. These experiments indicate that the functional defects associated with MNs can be directly attributed to MBNL family proteins. Comparative transcriptomic analyses also revealed specific neuronal‐related processes regulated by these proteins that are commonly misregulated in DM1. Conclusions Beyond the application to DM1, our approach to generating a robust and reliable human neuromuscular system should facilitate disease modelling studies and drug screening assays.

Year:

2023

Collaborators (4)

Edwin Chan

Professor

The Chinese University of Hong Kong (CUHK)

HONG KONG
View details

Ariadna Bargiela

Junio Principal Investigator

INCLIVA Health Research Institute

SPAIN
View details

Cécile Martinat

-

FRANCE
View details

C Andrew Frank

Professor

Iowa State University

UNITED STATES
View details